NCT07687342

Brief Summary

Stroke patients undergoing tracheostomy are at high risk of pulmonary complications because tracheostomy bypasses the normal upper airway defense mechanisms and increases the risk of airway colonization and infection. Although routine nursing care is widely used, a standardized quality improvement strategy for airway management remains lacking. This single-center, prospective, randomized, single-blind controlled trial aims to evaluate whether a PDCA (Plan-Do-Check-Act) cycle-based precision nursing program improves clinical outcomes in stroke patients with tracheostomy compared with routine nursing care. Eighty eligible participants will be randomly assigned in a 1:1 ratio to receive either the PDCA-based precision nursing intervention or routine nursing. The primary outcome is the incidence of pulmonary infection. Secondary outcomes include sputum viscosity, arterial blood gas parameters (PaO₂, PaCO₂, and oxygenation index), nursing satisfaction, and safety outcomes including unplanned extubation, incision infection, and airway mucosal injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Feb 2026

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 28, 2026

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 7, 2026

Completed
Last Updated

July 7, 2026

Status Verified

July 1, 2026

Enrollment Period

5 months

First QC Date

June 28, 2026

Last Update Submit

July 4, 2026

Conditions

Keywords

PDCA CyclePrecision NursingStrokeTracheostomyPulmonary InfectionAirway ManagementRandomized Controlled TrialNursing InterventionQuality ImprovementRespiratory Care

Outcome Measures

Primary Outcomes (1)

  • Incidence of Pulmonary Infection

    Pulmonary infection will be diagnosed by an independent physician who is blinded to treatment allocation according to the 2018 Chinese Guidelines for the Diagnosis and Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia. The incidence of pulmonary infection will be compared between the two study groups.

    From enrollment until hospital discharge or transfer, up to approximately 5 months

Secondary Outcomes (6)

  • Sputum Viscosity

    Baseline and hospital discharge or transfer, up to approximately 5 months

  • Partial Pressure of Oxygen

    Baseline and hospital discharge or transfer, up to approximately 5 months

  • Partial Pressure of Carbon Dioxide

    Baseline and hospital discharge or transfer, up to approximately 5 months

  • Oxygenation Index

    Baseline and hospital discharge or transfer, up to approximately 5 months

  • Nursing Satisfaction

    Within 24 hours before hospital discharge or transfer, up to approximately 5 months

  • +1 more secondary outcomes

Study Arms (2)

PDCA-Based Precision Nursing Group

EXPERIMENTAL

Participants in this group will receive routine nursing care plus a PDCA cycle-based precision nursing program from enrollment until hospital discharge or transfer. The intervention includes catheter safety management, continuous airway humidification, graded secretion management, standardized incision care, individualized airway clearance, aspiration prevention, and early rehabilitation training.

Behavioral: PDCA Cycle-Based Precision Nursing ProgramOther: Routine Nursing Care

Routine Nursing Group

ACTIVE COMPARATOR

Participants in this group will receive routine nursing care, including standard airway management, oxygen therapy, suctioning, nebulization, nutritional support, and routine tracheostomy wound care from enrollment until hospital discharge or transfer.

Other: Routine Nursing Care

Interventions

Routine nursing care includes standard airway management, oxygen therapy, suctioning, nebulization, nutritional support, and routine tracheostomy wound care according to usual clinical practice. It does not include the structured PDCA cycle-based precision nursing program.

PDCA-Based Precision Nursing GroupRoutine Nursing Group

The PDCA cycle-based precision nursing program is a structured nursing intervention delivered in addition to routine nursing care. It follows the Plan-Do-Check-Act quality improvement framework and includes catheter safety management, continuous airway humidification, graded secretion management, standardized incision care, individualized airway clearance, aspiration prevention, and early rehabilitation training. The intervention is implemented from enrollment until hospital discharge or transfer.

PDCA-Based Precision Nursing Group

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 30 to 80 years.
  • Diagnosis of first-ever stroke confirmed by computed tomography (CT) or magnetic resonance imaging (MRI) according to the Chinese Classification of Cerebrovascular Diseases (2015).
  • Underwent tracheostomy following stroke.
  • Not receiving mechanical ventilation or vasoactive drugs at enrollment.
  • No evidence of pulmonary infection at enrollment.
  • APACHE II score ≤20.
  • No severe dysfunction of major organs.
  • Written informed consent provided by the patient's legally authorized representative.

You may not qualify if:

  • Pulmonary infection before enrollment.
  • Severe respiratory failure, circulatory failure, or other severe organ failure.
  • Contraindications to rehabilitation because of neurological, musculoskeletal, or orthopedic disorders.
  • Hematologic diseases or severe coagulation disorders.
  • Inability to complete the study protocol or incomplete clinical data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, 215006, China

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
This is a single-blind study. Participants and care providers are aware of treatment allocation because of the nature of the nursing intervention. Outcome assessors and statisticians remain blinded to group assignment throughout the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to either the PDCA cycle-based precision nursing group or the routine nursing group. Both groups will receive their assigned intervention throughout hospitalization, and outcomes will be compared between the two parallel groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 28, 2026

First Posted

July 7, 2026

Study Start

February 1, 2026

Primary Completion

June 28, 2026

Study Completion

June 28, 2026

Last Updated

July 7, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because of participant privacy protection, institutional data management requirements, and the absence of prior consent for public data sharing.

Locations